ATOS
Atossa Therapeutics, Inc.
$2.49
+0.21 (+9.21%)
At close · Jul 7
Market Cap
$21.10M
Shares
8,611,361
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1758
-95.6%
FY2015
Net Income
-$34.77M
-36.3%
FY2025
Gross Margin
-7431.91%
-7531.9pp
FY2015
Operating Margin
-725746.19%
-695423.2pp
FY2015
Diluted EPS
-$4.04
-32.9%
FY2025
Operating Cash Flow
-$29.76M
-41.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1758 | — | — | — | — | — | — | — | — | — | — | $1758 | $40.14K | $632.56K | $481.84K | $1500 | — | |
| $132.41K | — | — | — | — | — | — | — | — | — | — | $132.41K | $0 | $345.52K | $35.75K | $5164 | — | |
| -$130.65K | — | — | — | — | — | — | — | — | — | — | -$130.65K | $40.14K | $137.09K | $416.21K | -$95.69K | — | |
| — | — | — | — | — | — | — | — | — | — | — | -7431.91% | 100% | 21.67% | 86.38% | -6379.33% | — | |
| $21.81M | $21.19M | $14.12M | $17.33M | $15.08M | $9.21M | $6.61M | $6.65M | $4.21M | $2.33M | $770.43K | $2.36M | $1.11M | $1.11M | $1.97M | — | — | |
| $17.79M | $15.96M | $13.5M | $14.04M | $12.61M | $11.31M | $8M | $10.62M | $7.22M | $4.86M | $6.48M | $8.85M | $8.05M | $8.56M | $3.04M | $3.17M | — | |
| — | — | — | — | — | — | $27.6K | $30.8K | $30K | $103.04K | — | — | — | — | — | — | — | |
| — | — | — | — | $8000 | $23K | $47K | $52.79K | $44.2K | $128.99K | $303.48K | $272.63K | $480.31K | $472.93K | $130.55K | $15.62K | — | |
| $39.6M | $37.14M | $27.62M | $31.38M | $27.69M | $20.52M | $14.61M | $17.27M | $11.43M | $7.65M | $7.97M | $12.63M | $12.21M | $10.92M | $5.49M | $3.33M | — | |
| -$39.6M | -$37.14M | -$27.62M | -$31.38M | -$27.69M | -$20.52M | -$14.61M | -$17.27M | -$11.43M | -$7.65M | -$7.97M | -$12.76M | -$12.17M | -$10.78M | -$5.07M | -$3.43M | — | |
| — | — | — | — | — | — | — | — | — | — | — | -725746.19% | -30322.96% | -1704.93% | -1052.01% | -228612.67% | — | |
| — | — | — | — | -$27.68M | -$20.5M | -$14.56M | -$17.21M | -$11.39M | -$7.52M | -$7.67M | -$12.49M | -$11.69M | -$10.31M | -$4.94M | -$3.41M | — | |
| $16.8K | — | — | — | — | — | — | — | — | — | — | — | $15.77K | $360 | $12.04K | $17.99K | — | |
| $1.97M | $2.38M | $4.05M | $4.34M | $877K | $6000 | — | — | — | — | — | — | $260 | $295 | $1219 | $4914 | — | |
| -$10K | -$6000 | -$223K | -$70K | -$146K | -$91K | $51K | $25.65K | $29.3K | $154 | $1.6M | $431 | $260 | — | — | — | — | |
| -$37.64M | -$34.77M | -$25.5M | -$30.09M | -$26.96M | -$20.61M | -$17.83M | -$17.24M | -$11.4M | -$8.12M | -$6.37M | -$12.76M | -$12.17M | -$10.78M | -$5.08M | -$3.44M | — | |
| $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | $0 | $0 | $0 | $0 | $0 | — | |
| -$37.64M | -$34.77M | -$25.5M | -$30.09M | -$26.96M | -$20.61M | -$17.83M | -$17.24M | -$11.4M | -$8.12M | -$6.37M | -$15.76M | -$14.66M | -$10.78M | -$5.08M | -$3.44M | -$1.09M | |
| — | — | — | — | — | — | — | — | — | — | — | -896491.64% | -36518.83% | -1704.94% | -1054.26% | -229484.53% | — | |
| — | — | — | — | — | -$20.61M | -$22.33M | -$17.24M | -$22.88M | -$10.69M | -$6.37M | — | — | — | — | — | — | |
| USD/shares | — | -$4.04 | -$3.04 | -$3.60 | -$3.15 | -$2.70 | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$4.04 | -$3.04 | -$3.60 | -$3.15 | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 8.61M | 8.39M | 8.41M | 8.44M | 7.8M | 753.9333 | 566.46K | 277.18K | 64.98K | 196.49K | 126.34K | 1.6M | 1.03M | 830.2K | 607.85K | — |
| shares | — | 8.61M | 8.39M | 8.41M | 8.44M | 7796.6667 | 753.9333 | 566.46K | 277.18K | 64.98K | 196.49K | 126.34K | 1.6M | 1.03M | 830.2K | 607.85K | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2024: $1.48M in buybacks.